As a positive control, we employed a potent inhibitor of anti-apoptotic Bcl-2 family members, Navitoclax, which beside its original function to target proliferating tumor cells has also been described to act as a powerful senolytic and apoptosis-inducing compound [11, 21]. Here, BCL2 is linked to neoplasm.